NEVRO CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
NEVRO CORP. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $61.17 per share as of 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2025-03-04
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $61.17.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $59.48.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $53.98.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $55.93.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2024-12-31 | $61.17 10-K · filed 2025-03-04 |
| 2023-12-31 | $59.48 10-K · filed 2025-03-04 |
| 2022-12-31 | $53.98 10-K · filed 2025-03-04 |
| 2021-12-31 | $55.93 10-K · filed 2025-03-04 |
| 2020-12-31 | $54.69 10-K · filed 2024-02-23 |
| 2019-12-31 | $50.80 10-K · filed 2023-02-21 |
| 2018-12-31 | $46.72 10-K · filed 2022-02-23 |
| 2017-12-31 | $43.62 10-K · filed 2021-02-24 |
| 2016-12-31 | $29.85 10-K · filed 2020-02-25 |
| 2015-12-31 | $19.74 10-K · filed 2019-02-21 |
| 2014-12-31 | $5.77 10-K · filed 2018-02-22 |
| 2013-12-31 | $2.88 10-K · filed 2017-02-23 |
| 2012-12-31 | $2.65 10-K · filed 2016-02-29 |
| 2011-12-31 | $2.64 10-K · filed 2015-03-18 |